OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · IEX Real-Time Price · USD
1.490
0.00 (0.00%)
At close: Mar 28, 2024, 3:28 PM
1.540
+0.050 (3.36%)
After-hours: Mar 28, 2024, 4:13 PM EDT

OKYO Pharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for OKYO Pharma stock has a target of 7.00, which predicts an increase of 369.80% from the current stock price of 1.49.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $7.00 $7.00 $7.00
Change +369.80% +369.80% +369.80% +369.80%

Analyst Ratings

According to 1 stock analyst, the rating for OKYO Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 11111
Buy 00000
Hold 00000
Sell 00000
Strong Sell 00000
Total 11111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$6$7
Strong Buy Maintains $6$7 +369.80% Mar 22, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$4$5
Strong Buy Maintains $4$5 +235.57% Jan 8, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +168.46% Dec 5, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$4
Strong Buy Initiates $4 +168.46% Nov 2, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.41
from -0.61
EPS Next Year
-0.39
from -0.41
Year 201920202021202220232024
Revenue
------
Revenue Growth
------
EPS
--0.32-0.36-0.61-0.41-0.39
EPS Growth
------
No. Analysts ----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20232024
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20232024
High - -
Avg - -
Low - -

EPS Forecast

EPS 20232024
High -0.42 -0.40
Avg -0.41 -0.39
Low -0.39 -0.37

EPS Growth

EPS Growth 20232024
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.